Quantbot Technologies LP Roivant Sciences Ltd. Transaction History

Quantbot Technologies LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	BUY	$7.09 - $10.08 $98,409 - $139,910	13,880 Added 69400.0%	13,900 $140,000
Q1 2023 May 12, 2023	SELL	$6.92 - $9.98 $224,526 - $323,811	-32,446 Reduced 99.94%	20 $0
Q4 2022 Feb 13, 2023	BUY	$3.36 - $7.99 $109,085 - $259,403	32,466 New	32,466 $259,000
Q1 2022 May 16, 2022	SELL	$4.74 - $9.91 $7,584 - $15,856	-1,600 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$5.86 - $13.52 $9,376 - $21,632	1,600 New	1,600 $16,000

314

495M

1.29M

1.15M

Ticker ROIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 704,382,976
Market Cap $8.28B
Description
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.